Status and prospects of liver cirrhosis treatment by using bone marrow-derived cells and mesenchymal cells

Tissue Engineering - Part B: Reviews

Volumn 20, Issue 3, 2014, Pages 206-210

  Terai, Shuji ^a   Takami, Taro ^a   Yamamoto, Naoki ^b   Fujisawa, Koichi ^a   Ishikawa, Tsuyoshi ^a   Urata, Yohei ^a   Tanimoto, Haruko ^a   Iwamoto, Takuya ^a   Mizunaga, Yuko ^a   Matsuda, Takashi ^a   Oono, Takashi ^a   Marumoto, Miho ^a   Burganova, Guzel ^a,c,d   Quintanilha, Luiz Fernando ^a,e   Hidaka, Isao ^a   Marumoto, Yoshio ^a   Saeki, Issei ^a   Uchida, Koichi ^a   Yamasaki, Takahiro ^a   Tani, Kenji ^b   Taura, Yasuho ^b   Fujii, Yasuhiko ^f   Nishina, Hiroshi ^g   Okita, Kiwamu ^a   Sakaida, Isao ^a   more..

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

^c KAZAN STATE MEDICAL UNIVERSITY   (Russian Federation)

^d KAZAN FEDERAL UNIVERSITY   (Russian Federation)

^e FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^f YAMAGUCHI UNIVERSITY HOSPITAL   (Japan)

^g TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHESIOLOGY; BIOMEDICAL ENGINEERING; BONE; CELL CULTURE; CELLS; DESIGN;

ALCOHOL CONSUMPTION; BONE MARROW CELLS; GENERAL ANESTHESIAS; MEDICAL TECHNOLOGIES; MESENCHYMAL CELLS; MESENCHYMAL STEM CELL; STATUS AND PROSPECT; TRANSLATIONAL RESEARCH;

PATIENT TREATMENT;

ARTICLE; BONE MARROW CELL; CELL ACTIVATION; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; MESENCHYME CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TRANSLATIONAL RESEARCH; ANIMAL; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; FORECASTING; LIVER REGENERATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; PATHOLOGY; PHYSIOLOGY; TISSUE ENGINEERING; TRENDS;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; FORECASTING; HUMANS; LIVER CIRRHOSIS; LIVER REGENERATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; TISSUE ENGINEERING;

EID: 84900012743     PISSN: 19373368     EISSN: 19373376     Source Type: Journal    
DOI: 10.1089/ten.teb.2013.0527     Document Type: Article

References (18)

1. Theise, N.D., Badve, S., Saxena, R., Henegariu, O., Sell, S., Crawford, J.M., and Krause, D.S. Derivation of hepatocytes from BMCs in mice after radiation-induced myeloablation. Hepatology 31, 235, 2000.
2. Terai, S., Sakaida, I., Yamamoto, N., Omori, K., Watanabe, T., Ohata, S., Katada, T., et al. An in vivo model for monitoring trans-differentiation of BMCs into functional hepatocytes. J Biochem (Tokyo) 13, 551, 2003.
3. Terai, S., Sakaida, I., Nishina, H., and Okita, K. Lesson from the GFP/CCl4 model-translational research project: the development of cell therapy using autologous BMCs in patients with liver cirrhosis. J Hepatobiliary Pancreat Surg 12, 203, 2005.
4. Sakaida, I., Terai, S., Yamamoto, N., Aoyama, K., Ishikawa, T., Nishina, H., and Okita, K. Transplantation of BMCs reduces CCl4-induced liver fibrosis in mice. Hepatology 40, 1304, 2004.
5. Iimuro, Y., Nishio, T., Morimoto, T., Nitta, T., Stefanovic, B., Choi, S.K., Brenner, D.A., et al. Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat. Gastroenterology 124, 445, 2003.
6. Higashiyama, R., Inagaki, Y., Hong, Y.Y., Kushida, M., Nakao, S., Niioka, M., Watanabe, T., et al. Bone marrowderived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice. Hepatology 45, 213, 2007.
7. Siller-Lopez, F., Sandoval. A., Salgado, S., Salazar, A., Bueno, M., Garcia, J., Vera, J., et al. Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis. Gastroenterology 126, 1122, 2004;
8. Terai, S., Ishikawa, T., Omori, K., Aoyama, K., Marumoto, Y., Urata, Y., Yokoyama, Y., et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 24, 2292, 2006.
9. Kim, J.K., Park, Y.N., Kim, J.S., Park, M.S., Paik, Y.H., Seok, J.Y., Chung, Y.E., et al. Autologous bone marrow infusion activates the progenitor cell compartment in patients with advanced liver cirrhosis. Cell Transplant 19, 1237, 2010.
10. Saito, T., Okumoto, K., Haga, H., Nishise, Y., Ishii, R., Sato, C., Watanabe, H., et al. Potential therapeutic application of intravenous autologous bone marrow infusion in patients with alcoholic liver cirrhosis. Stem Cells Dev 20, 1503, 2011.
11. Mizunaga, Y., Terai, S., Yamamoto, N., Uchida, K., Yamasaki, T., Nishina, H., Fujita, Y., Shinoda, K., Hamamoto, Y., and Sakaida, I. Granulocyte colony-stimulating factor and interleukin-1b are important cytokine in repair of the cirrhotic liver after bone marrow cell infusion-comparison of humans and model mice. Cell Transplant 21, 2363, 2012.
12. Iwamoto, T., Tera, S., Mizunaga, Y., Yamamoto, N., Omori, K., Uchida, K., Yamasaki, T., et al. Splenectomy enhances the anti-fibrotic effect of bone marrow cell infusion and improves liver function in cirrhotic mice and patients. J Gastroenterol 47, 300, 2012.
13. Gholamrezanezhad, A., Mirpour, S., Bagheri, M., Mohamadnejad, M., Alimoghaddam, K., Abdolahzadeh, L., Saghari, M., et al. In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis. Nucl Med Biol 38, 961, 2011.
14. Peng, L., Xie, D.Y., Lin, B.L., Liu, J., Zhu, H.P., Xie, C., Zheng, Y.B., et al. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes. Hepatology 54, 820, 2011.
15. Maeda, M., Takami, T., Terai, S., and Sakaida, I. Autologous bone marrow cell infusions suppress tumor initiation in hepatocarcinogenic mice with liver cirrhosis. J Gastroenterol Hepatol 27 Suppl 2, 104, 2012.
16. Terai, S., Tanimoto, H., Maed, M., Zaitsu, J., Hisanaga, T., Iwamoto, T., Fujisawa, K., et al. Timeline for development of autologous bone marrow infusion (ABMi) therapy and perspective for future stem cell therapy. J Gastroenterol 47, 491, 2012.
17. Mohamadnejad, M., Namiri, M., Bagheri, M., Hashemi, S.M., Ghanaati, H., Zare Mehrjardi, N., Kazemi Ashtiani, S., et al. Phase 1 human trial of autologous bone marrowhematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol 13, 3359, 2007.
18. Tanimoto, H., Terai, S., Takami, T., Murata, Y., Fujisawa, K., Yamamoto, N., and Sakaida, I. Improvement of liver fibrosis by infusion of cultured cells derived from human bone marrow. Cell Tissue Res 354, 717, 2013.